Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S21 pseudogene refers to a genomic DNA sequence resembling the gene encoding ribosomal protein S21 but lacking the capacity to code for a functional protein. Pseudogenes are considered molecular fossils—remnants of once-active genes that have accumulated mutations resulting in loss of function, such as premature stop codons or frameshifts[11][2]. There are multiple processed pseudogenes for ribosomal protein S21 distributed throughout the human genome[11][2]. These pseudogenes do not encode functional ribosomal proteins, are not transcribed into functional RNA or protein, and have no direct role in cell biology, therapy, or disease[11][2][1]. Their presence is sometimes used in genome structure analysis or as evolutionary markers. The canonical functional gene is RPS21 (ribosomal protein S21), a component of the 40S small ribosomal subunit responsible for protein synthesis in the cytoplasm[1][10][12]. Note: If you are seeking information about the protein-coding ribosomal protein S21 gene (RPS21, ENSG00000171858), it is a small ribosomal subunit protein involved in translation, but its pseudogenes are not therapeutic targets[1][10][7].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S21 pseudogene (RPS21P).